Clinical Trials Directory

Trials / Completed

CompletedNCT01459042

Prevalence of Primary Aldosteronism in Patients With Resistant Hypertension in China

Prevalence of Primary Aldosteronism and Status of Renin-Angiotensin System in Resistant Hypertension:An Observational Study in China

Status
Completed
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Recent studies indicate that primary aldosteronism (PA) is a much more common cause of hypertension than had been demonstrated historically. In patients with resistant hypertension, the prevalence of PA from different clinics worldwide is about 10-20%. As has been no such data in China, the investigators are conducting a PA study in different province of China to evaluate the prevalence of PA in patients with resistant hypertension.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2011-10-01
First posted
2011-10-25
Last updated
2011-10-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01459042. Inclusion in this directory is not an endorsement.